Furthermore, it decreases the hepatic expression of inflammatory cytokines (e.g., TNF-α, interleukin-6, and Monocyte Chemoattractant Protein-1 (MCP-1)) in NASH patients. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.